Literature DB >> 16556961

Effectiveness of virtual reality exposure in the treatment of arachnophobia using 3D games.

Stéphane Bouchard1, Sophie Côté, Julie St-Jacques, Geneviève Robillard, Patrice Renaud.   

Abstract

Buying or creating a virtual reality (VR) software is very costly. A less expensive alternative could be to modify already existing 3D computer games. The goal of this study is to assess the effectiveness of in virtuo exposure in the treatment of arachnophobia using modified 3D games. Participants were 10 women and 1 man. Virtual worlds were created using the game editor of a 3D computer game (Half-Life), modified to offer graduals hierarchies of fearful stimuli (spiders). Analyses revealed significant improvement between pre and post results on the behavioral avoidance test, the Spider Beliefs Questionnaire, and perceived self-efficacy. These promising results suggest that therapy using virtual reality exposure via a modified computer game is useful in the treatment of arachnophobia.

Entities:  

Mesh:

Year:  2006        PMID: 16556961

Source DB:  PubMed          Journal:  Technol Health Care        ISSN: 0928-7329            Impact factor:   1.285


  12 in total

Review 1.  Virtual reality exposure therapy for post-traumatic stress disorder and other anxiety disorders.

Authors:  Maryrose Gerardi; Judith Cukor; Joann Difede; Albert Rizzo; Barbara Olasov Rothbaum
Journal:  Curr Psychiatry Rep       Date:  2010-08       Impact factor: 5.285

2.  Effect of the "Art Coloring" Online Coloring Game on Subjective Well-Being Increase and Anxiety Reduction During the COVID-19 Pandemic: Development and Evaluation.

Authors:  JuZhe Xi; YuHan Gao; Na Lyu; Zhuang She; XinYue Wang; Xin-An Zhang; XiaoYu Yu; WeiDong Ji; MengSheng Wei; WeiHui Dai; Xuesheng Qian
Journal:  JMIR Serious Games       Date:  2022-07-08       Impact factor: 3.364

Review 3.  Virtual Reality-Enhanced Extinction of Phobias and Post-Traumatic Stress.

Authors:  Jessica L Maples-Keller; Carly Yasinski; Nicole Manjin; Barbara Olasov Rothbaum
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

Review 4.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

5.  Virtual Reality Exposure Therapy for Anxiety Disorders: Small Samples and No Controls?

Authors:  Sarah Page; Matthew Coxon
Journal:  Front Psychol       Date:  2016-03-11

6.  In Vivo versus Augmented Reality Exposure in the Treatment of Small Animal Phobia: A Randomized Controlled Trial.

Authors:  Cristina Botella; M Ángeles Pérez-Ara; Juana Bretón-López; Soledad Quero; Azucena García-Palacios; Rosa María Baños
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

7.  Video gaming and gaming addiction in transgender people: An exploratory study.

Authors:  Jon Arcelus; Walter Pierre Bouman; Bethany Alice Jones; Christina Richards; Susana Jimenez-Murcia; Mark D Griffiths
Journal:  J Behav Addict       Date:  2017-02-15       Impact factor: 6.756

8.  0Phobia - towards a virtual cure for acrophobia: study protocol for a randomized controlled trial.

Authors:  T Donker; S Van Esveld; N Fischer; A Van Straten
Journal:  Trials       Date:  2018-08-09       Impact factor: 2.279

9.  A meta-analysis on the relationship between self-reported presence and anxiety in virtual reality exposure therapy for anxiety disorders.

Authors:  Yun Ling; Harold T Nefs; Nexhmedin Morina; Ingrid Heynderickx; Willem-Paul Brinkman
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

10.  Olfactory Stimuli Increase Presence in Virtual Environments.

Authors:  Benson G Munyan; Sandra M Neer; Deborah C Beidel; Florian Jentsch
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.